Global Catheter Market will reach USD 46.20 Billion by

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
101
Global Catheter Market will reach USD 46.20 Billion by 2021: Zion Market Research

Sarasota, FL, May 16, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Catheter Market by Product (Cardiovascular, Urology, Intravenous, Neurovascular and Specialty Catheters) - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2015 – 2021” .  According to the report, the  global catheter market  was valued at USD 26.60 billion in 2015 and expected to reach USD 46.20 billion by 2021, growing at a CAGR of 9.7% between 2016 and 2021. In terms of volume, global catheter market stood at 10,174.25 million units in 2015.

The catheter is a thin sterilized tube made from medical grade materials and can offer a broad range of medical conditions. Catheters can also be inserted into a body cavity, duct or vessel for drainage, administration of fluids or gasses. Catheters used to access for surgical instruments and also to perform a wide variety of other tasks depending upon the type of catheter. 

Browse through 19 Market Tables and 30 Figures spread through 110 Pages and in-depth TOC on “Global Catheter Market: By Type, Product, Industry Size, Share, Trends, Segment Analysis, and, Forecast 2015-2021”.

Request Free Sample copy of Global Catheter Market Report @ https://www.zionmarketresearch.com/sample/catheter-market

Globally, catheters market is driven mainly due to the continuous rise in population of cardiovascular disorders patients across the world. Diabetes, tachycardia, hypertension are no more rare among individuals.  At present, each country has shown the marked rise in diabetes and hypertension patients supported by various lifestyle factors which include smoking, drinking, and sedentary lifestyle. These factors increasing demand for minimally invasive surgeries which propel the growth of global catheter market. In addition, growing aging population, favorable reimbursement policies and increasing demand for advanced urinary catheters are major factors leading to increased demand for urinary catheters, thereby fuelling the growth of the catheter market. However, the incidences of nosocomial urinary tract infection caused by catheter are likely to be a restraint for the growth of global catheter market. Nonetheless, ongoing research and development in medical and healthcare sector are likely to bring new growth avenues in medical device industry. Based on product, the global catheter market is segmented into five types: cardiovascular catheter, neurovascular catheter, urological catheter, intravenous catheter and specialty catheters. Specialty catheters dominated the catheter market in 2015 followed by the cardiovascular catheter. Cardiovascular catheters account for approximately 30% share of global catheter market, whereas intravenous catheters account for approximately 14% share of total catheter market. The growth of the cardiovascular catheters market is attributed to the abnormal or sudden increase in cardiovascular diseases which include diabetes, coronary heart diseases, agina pectoris and other heart-related diseases. Different type of cardiovascular catheters utilized by practitioners dealing with heart diseases includes a guiding catheter, balloon catheters, intravascular ultrasound catheters, angiography catheters, pulmonary artery catheters and others. Growing percentage of heart surgery is considered as a major driving factor for the cardiovascular catheter market. The cardiovascular catheter is the second largest segment in terms of generating revenue.

Browse the full " Catheter Market by Product (Cardiovascular, Urology, Intravenous, Neurovascular and Specialty Catheters) - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021 " report at  https://www.zionmarketresearch.com/report/catheter-market

North America was the dominating region for catheter market in 2015. The growth was accredited due to rising incidence of kidney problem in the U.S. In addition, rising prevalence of diabetes and other cardiovascular disorder in individuals considered as major driving factors for the growth of catheters market in this region. Moreover, high-end research and technological advancements, increasing consultant interest are the important key factors which drive the demand of catheter market in this region. Higher healthcare expenditure and encouraging healthcare infrastructure in this region are other growth factors for catheter market. North America accounted for approximately more than 37% of total revenue of catheter market. In addition, the presence of a large number of biopharmaceutical firms, leading market players and research institutes in North America played a significant role in driving the catheters market.

Europe holds the second largest market shares in term of revenue for catheter market. In 2015, Europe shares approximately 29.0% of total catheter market. The growth is credited due to the presence the of a number of countries with high development index in Europe. Europe is expected to continue to hold the second largest market for global catheter market in 2015. This growth is mainly associated with advancement in technological and healthcare research in this region. 

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/catheter-market

The Asia-Pacific region may offer significant opportunities for the catheter market during the forecast period. At present, China and India being the most populous countries in this region are contributing to the increased demand for catheter devices which are utilized for the cardiovascular, urinary and neurological disorder. China is the second-largest economy after the U.S. It is home to the world’s largest population with close to 1.37 billion inhabitants followed by India with approximately 1.28 billion people in 2015. These two countries contribute approximately 40% of total world population. Rising percentage of cardiovascular patients in Asia-Pacific region is considered as a major driving factor for collecting revenue for catheters market after Europe.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/283

Key market players of catheter market include Abbott Laboratories, Becton Dickinson Inc., Boston Scientific, Bard Medicals, Braun Melsungen AG, Arrow International Inc., Johnson and Johnson, Medtronic Inc., Rochester Medical Co., Edwards Lifesciences, Hollister Inc., Medrad (Bayer AG) and Vascular Solutions.

Directly Purchase a copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/catheter-market

This report segments the global catheters market as follows: Global Catheters Market: Product Segment Analysis

  • Cardiovascular Catheters
  • Neurovascular Catheters
  • Urological Catheters
  • Intravenous Catheters
  • Specialty Catheters

Global Catheters Market: Regional Segment Analysis

  • North America
    • U.S. 
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
  • Latin America
    • Brazil 
  • Middle East & Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research Follow Us Twitter: https://twitter.com/zion_research

Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 16

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 9

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 12

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 15

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 5

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 15

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Updated Category News Views 7

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 12

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 12

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 15

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading

Top 5 Most Recently Viewed Articles

Ikena Oncology and Inmagene Form Strategic Merger to Advance Cancer Therapies

Updated Category News Views 137

Overview of the Merger and Collaboration Ikena Oncology, Inc. and Inmagene Biopharmaceuticals have announced an exciting merger agreement that aims to amplify their efforts in developing innovative treatment options for patients suffering from inflammatory diseases. The merger is designed to streamline the development of IMG-007, a cutting-edge therapeutic candidate...

Continue Reading
Tempest’s Amezalpat Therapy Receives Crucial Approval in China

Updated Category News Views 209

Tempest Therapeutics Advances Amezalpat in Pivotal Trial Tempest Therapeutics, Inc. (Nasdaq: TPST) is thrilled to announce a major step forward in the fight against hepatocellular carcinoma (HCC), having received approval from China’s National Medical Products Administration (NMPA) to initiate a pivotal trial. This trial aims to evaluate the efficacy of amezalpat...

Continue Reading
Chicago Atlantic BDC, Inc. Announces Impressive Dividend Payout

Updated Category News Views 96

Chicago Atlantic BDC, Inc. Announces Dividend for the Upcoming Quarter In a notable development, Chicago Atlantic BDC, Inc. has declared a cash dividend of $0.34 per share for the upcoming quarter. This announcement is a significant milestone for shareholders, reflecting the company's solid financial foundation and commitment to returning value to its investors. This...

Continue Reading
Be Bio Secures $92 Million to Propel Clinical Innovations

Updated Category News Views 186

Be Bio Secures $92 Million to Propel Clinical Innovations Be Biopharma, Inc. (NASDAQ: BIO), a front-runner in B Cell Medicines, has successfully closed a significant $92 million Series C financing round. This milestone will undoubtedly bolster their mission of advancing innovative therapies. The financing has drawn interest from a mix of new and existing investors,...

Continue Reading
Lifecore Biomedical's Q2 2025 Financial Results Announcement

Updated Category News Views 226

Lifecore Biomedical to Report Second Quarter Financial Results Lifecore Biomedical, Inc. (NASDAQ: LFCR), a prominent contract development and manufacturing organization (CDMO), is gearing up to share its financial outcomes for the second quarter of fiscal year 2025. The report is scheduled for January 2, 2025, after the market closes. This presentation is highly...

Continue Reading